[ARS] Medicus Pharma Ltd. SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

06/30/2025 - 05:01 PM

ARS - Medicus Pharma Ltd.

ARS Filing - Medicus Pharma Ltd.

This filing is available as a PDF document.

Filing Type: ARS

Company: Medicus Pharma Ltd. (MDCX)

Acceptance Date: 2025-06-30T17:01:04.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Medicus Pharma Ltd

NASDAQ:MDCX

MDCX Rankings

#5676 Ranked by Market Cap

N/A Ranked by Dividends

MDCX Latest News

Dec 22, 2025

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform

Dec 15, 2025

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Dec 5, 2025

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

Dec 1, 2025

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President

Nov 24, 2025

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

MDCX Latest SEC Filings

Dec 8, 2025

[8-K] Medicus Pharma Ltd. Reports Material Event

Dec 18, 2025

[Form 4] Medicus Pharma Ltd. Insider Trading Activity

Dec 18, 2025

[Form 4] Medicus Pharma Ltd. Insider Trading Activity

Dec 18, 2025

[Form 4] Medicus Pharma Ltd. Insider Trading Activity

Dec 18, 2025

[Form 4] Medicus Pharma Ltd. Insider Trading Activity

MDCX Stock Data

Market Cap 38.30M

Float 14.73M

Insiders Ownership 35.91%

Institutions Ownership 14.9%

Short Percent 1.87%

Industry Drug Manufacturers - General

Sector Pharmaceutical Preparations

Website Link

Country Canada

City W. CONSHOHOCKEN